Search Results - "Rotundo MS"

Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center.

Authors: Rotundo MS Zampino MG Ravenda PS et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Jul 15; Vol. 12, pp. 1758835920940945. Date of Electronic Publication: 2020 Jul 15 (Print Publication: 2020).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Expression of FoxP3+ Tregs and its Association with Stage and Grade of Colorectal Cancer Patients.

Authors: Md Nasir, Md Najmi Paiman, Noorasmaliza Md Zakaria, Andee Dzulkarnaen et al.

Source: Malaysian Journal of Medicine & Health Sciences. Jul2025, Vol. 21 Issue 4, p286-294. 9p.

Upregulation of the ZNF148/PTX3 axis promotes malignant transformation of dendritic cells in glioma stem‐like cells microenvironment.

Authors: Cheng, Shan Liu, Liang Wang, Delin et al.

Source: CNS Neuroscience & Therapeutics. Sep2023, Vol. 29 Issue 9, p2690-2704. 15p.

PD-1/PD-L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta-analysis of randomized trials.

Authors: Rotundo MS Bagnardi V Rotundo M et al.

Source: Oncology letters [Oncol Lett] 2022 Apr; Vol. 23 (4), pp. 134. Date of Electronic Publication: 2022 Feb 23.

Publication Type: Journal Article

Journal Info: Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1792-1082 (Electronic) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE

FKBP5 isoforms shape immune pathways related to tumor tolerance.

Authors: Romano S Marrone L Acanfora G et al.

Source: Cell death discovery [Cell Death Discov] 2026 Mar 26; Vol. 12 (1). Date of Electronic Publication: 2026 Mar 26.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.

Authors: Zhong, Zhaoming Hong, Min Chen, Xiao et al.

Source: BMC Medical Genomics. 3/30/2020, Vol. 13 Issue 1, p1-11. 11p.

Incidence, Risk Factors, and Management of Radiotherapy-Related Skin Toxicity in Rectoanal Cancer Patients: a Systematic Review and Meta-Analysis.

Authors: He Y Wang M Gao C et al.

Source: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2026 Jan 15; Vol. 57 (1), pp. 16. Date of Electronic Publication: 2026 Jan 15.

Publication Type: Journal Article; Meta-Analysis; Network Meta-Analysis; Systematic Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab.

Authors: Giannicola, Rocco D'Arrigo, Graziella Botta, Cirino et al.

Source: Molecular & Clinical Oncology. Jul2019, Vol. 11 Issue 1, p81-90. 10p.

ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression.

Authors: Yang, Zijiang Gao, Aiqin Shi, Wenjing et al.

Source: OncoTargets & Therapy. Jul2021, Vol. 14, p4239-4254. 16p.

mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials.

Authors: Rotundo MS Galeano T Tassone P et al.

Source: Oncotarget [Oncotarget] 2016 May 10; Vol. 7 (19), pp. 27055-66.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review.

Authors: Noori, Maryam Jafari-Raddani, Farideh Davoodi-Moghaddam, Zeinab et al.

Source: Cancer Cell International. 1/5/2024, Vol. 24 Issue 1, p1-29. 29p.

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.

Authors: Li, Jiangping Xiao, Zhiwen Wang, Donghui et al.

Source: Molecular Cancer. 8/30/2023, Vol. 22 Issue 1, p1-56. 56p.

mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity.

Authors: Patel, Jaimin Nguyen, Shaun A. Ogretmen, Besim et al.

Source: Laryngoscope Investigative Otolaryngology. Apr2020, Vol. 5 Issue 2, p243-255. 13p.

Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors: Hu, Xingsheng Pu, Ke Feng, Xuqin et al.

Source: PLoS ONE. 3/8/2016, Vol. 11 Issue 3, p1-18. 18p.

Necrotizing fasciitis caused by Haemophilus influenzae type b in a patient with rectal cancer treated with combined bevacizumab and chemotherapy: a case report.

Authors: Tomotaka Ugai Masataro Norizuki Takahiro Mikawa et al.

Source: BMC Infectious Diseases. 2014, Vol. 14 Issue 1, p1-7. 7p.

An immunologic portrait of cancer.

Source: Journal of Translational Medicine. 2011, Vol. 9 Issue 1, p146-158. 13p. 1 Diagram, 1 Chart, 1 Graph.

Improving the synergistic combination of programmed death‐1/programmed death ligand‐1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment.

Authors: Mudassar, Faiqa Shen, Han Cook, Kristina M et al.

Source: Journal of Medical Imaging & Radiation Oncology. Jun2022, Vol. 66 Issue 4, p560-574. 15p.

Combination strategies to maximize the benefits of cancer immunotherapy.

Authors: Zhu, Shaoming Zhang, Tian Zheng, Lei et al.

Source: Journal of Hematology & Oncology. 9/27/2021, Vol. 14 Issue 1, p1-33. 33p.

Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy.

Authors: Wang, Bin Zhao, Qin Zhang, Yuyu et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 1/9/2021, Vol. 40 Issue 1, p1-16. 16p.

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.

Source: Journal of Translational Medicine. 2011, Vol. 9 Issue 1, p174-195. 22p. 3 Diagrams, 2 Charts.